Subjects: Drug Costs / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug Costs ✖ Copyright Public domain ✖

1. Calculation of potential inflation-indexed rebates for Medicare Part B drugs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Cost Control
Cost Savings
Medicaid -- economics
Humans
United States
United States. Department of Health and Human Services.

2. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2017
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare Part B -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

3. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Medicare -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

4. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2017
Subject(s):: Drug Costs
Insurance, Pharmaceutical Services -- economics
Medicare Part B -- economics
Prospective Payment System
Abatacept -- economics
Certolizumab Pegol -- economics
Cost Savings
Injections -- economics
Self Care -- economics
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
Healthcare common procedure coding system

5. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017
Subject(s):: Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
Insurance, Health, Reimbursement
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

6. Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018
Subject(s):: Drug Costs
Insurance, Health, Reimbursement
Medicare Part B -- economics
Cost Savings
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

7. The Medicaid Drug Rebate Program: the basics

Publication:: Washington, D.C. : George Washington University, [2009]
Subject(s):: Drug Costs
Economics, Pharmaceutical
Medicaid -- economics
Health Expenditures
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

8. Coverage and payment for prescription drugs under Medicare Part B: a complex patchwork

Publication:: Washington, D.C. : George Washington University, [2009]
Subject(s):: Health Care Reform -- economics
Insurance, Pharmaceutical Services
Medicare Part B -- economics
Prospective Payment System -- economics
Cost Sharing
Drug Costs
Medicare Part D -- economics
Humans
United States

9. Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis

Author(s):: Anderson-Cook, Anna, author
Maeda, Jared, author
Nelson, Lyle, author
Publication:: [Washington, DC] : Congressional Budget Office, March 2019
Subject(s):: Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States

10. Prices for and spending on specialty drugs in Medicare Part D and Medicaid

Publication:: [Washington, DC] : Congressional Budget Office, March 2019
Subject(s):: Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs
Economics, Pharmaceutical -- trends
Forecasting
Medicaid -- trends
Medicare Part D -- trends
Orphan Drug Production -- economics
Humans
United States